Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDPK1 | O15530 | 1/20 | 0.44 |
| ▸ | PPARG | P37231 | 6/20 | 0.41 |
| ▸ | PPARA | Q07869 | 5/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | SRC | P12931 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.39 |
| ▸ | FABP7 | O15540 | 1/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5640880 | 1.00 | PDPK1 (0.44) | PDPK1PPARGPPARACYP2D6SRC | |
| SCHEMBL5642476 | 1.00 | PDPK1 (0.44) | PDPK1PPARGPPARACYP2D6SRC | |
| Hydrochloric Acid SCHEMBL8847169 | 0.98 | PDPK1 (0.43) | PDPK1PPARGPPARACYP2D6SRC | |
| Hydrochloric Acid SCHEMBL668327 | 0.98 | PDPK1 (0.43) | PDPK1PPARGPPARACYP2D6SRC | |
| SCHEMBL7344512 | 0.86 | EPHX2 (0.41) | PPARGPPARALMNAEPHX2 | |
| SCHEMBL11825339 | 0.86 | EPHX1 (0.41) | PDPK1CYP2D6LMNAMAPK1FABP7 | |
| SCHEMBL527394 | 0.86 | PDPK1 (0.39) | PDPK1PPARGPPARALMNAFABP7 | |
| SCHEMBL7341580 | 0.84 | PNMT (0.51) | PPARGPPARA | |
| SCHEMBL8171416 | 0.83 | KMT2A (0.50) | LMNA | |
| SCHEMBL7344139 | 0.83 | MEN1 (0.48) | PPARGPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 293 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115297858-B | Pharmaceutical composition for treating hypertrophic cardiomyopathy and treatment method using the same | 赛特瑞恩股份有限公司 | 2024-08-13 | — | — | CN | claimed |
| US-20230190708-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION | CELLTRION, INC. (KR) | 2023-06-22 | — | — | US | claimed |
| EP-4140482-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION | Celltrion, Inc. (KR) | 2023-03-01 | — | — | EP | claimed |
| CN-115297858-A | Pharmaceutical composition for treating hypertrophic cardiomyopathy and treatment method using same | 赛特瑞恩股份有限公司 | 2022-11-04 | — | — | CN | claimed |
| EP-3440065-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE BERAPROST | EUROAPI HUNGARY LLC (HU) | 2022-06-08 | — | — | EP | claimed |
| US-10421737-B2 | Process for the preparation of optically active Beraprost | CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE COMPANY LTD. (HU) | 2019-09-24 | — | — | US | claimed |
| EP-3140265-B1 | PROCESS FOR OBTAINING OPTICALLY ACTIVE PIRLINDOLE ENANTIOMERS AND SALTS THEREOF | TECNIMEDE SOCIEDADE TECNICO MEDICINAL S (PT) | 2019-08-28 | — | — | EP | claimed |
| EP-3440065-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE BERAPROST | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) | 2019-02-13 | — | — | EP | claimed |
| WO-2017174439-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE BERAPROST | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) | 2017-10-12 | — | — | WO | claimed |
| US-8653283-B2 | Anticancer agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-02-18 | — | — | US | claimed |
| EP-2331545-B1 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE&NEW IMPURITIES IN PREPARATION THEREOF | CADILA HEALTHCARE LTD (IN) | 2013-10-02 | — | — | EP | claimed |
| EP-1598337-B1 | METHOD OF OBTAINING AN ANTIEPILEPTIC AGENT | ESTEVE QUIMICA SA (ES) | 2012-05-09 | — | — | EP | claimed |
| US-20120083527-A1 | Anticancer Agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-04-05 | — | — | US | claimed |
| US-20110213149-A1 | PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE & NEW IMPURITIES IN PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2011-09-01 | — | — | US | claimed |
| EP-2331545-A2 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE&NEW IMPURITIES IN PREPARATION THEREOF | Cadila Healthcare Limited (IN) | 2011-06-15 | — | — | EP | claimed |
| WO-2010032264-A2 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE & NEW IMPURITIES IN PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2010-03-25 | — | — | WO | claimed |
| US-7291746-B2 | Process for obtaining an antiepileptic agent | ESTEVE QUIMICA, S.A. (ES) | 2007-11-06 | — | — | US | claimed |
| US-20060142376-A1 | Method for obtaining an antiepileptic agent | ESTEVE QUIMICA, S.A. (ES) | 2006-06-29 | — | — | US | claimed |
| EP-1598337-A1 | METHOD OF OBTAINING AN ANTIEPILEPTIC AGENT | Farma-Lepori S.A. (ES) | 2005-11-23 | — | — | EP | claimed |
| EP-4469466-A1 | C25 R AND S ISOMERS OF AMINOSTEROLS AND METHODS OF MAKING AND USING THE SAME | Enterin, Inc. (US) | 2024-12-04 | — | — | EP | disclosed |
| CN-115297858-B | Pharmaceutical composition for treating hypertrophic cardiomyopathy and treatment method using the same | 赛特瑞恩股份有限公司 | 2024-08-13 | — | — | CN | disclosed |
| WO-2023146842-A1 | C25 R AND S ISOMERS OF AMINOSTEROLS AND METHODS OF MAKING AND USING THE SAME | ENTERIN, INC. (US) | 2023-08-03 | — | — | WO | disclosed |
| US-20230190708-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION | CELLTRION, INC. (KR) | 2023-06-22 | — | — | US | disclosed |
| EP-4140482-A1 | PHARMACEUTICAL COMPOSITION FOR TREATMENT OF HYPERTROPHIC CARDIOMYOPATHY AND TREATMENT METHOD USING SAME COMPOSITION | Celltrion, Inc. (KR) | 2023-03-01 | — | — | EP | disclosed |
| CN-109219601-B | Method for preparing optically active beraprost | 奇诺因药物和化学工厂私人有限公司 | 2022-08-09 | — | — | CN | disclosed |
| EP-4022293-A1 | OPTIMIZED ANALYTE DERIVATIZATION FOR SYNERGISTIC APPLICATION WITH CRYSTAL SPONGE METHOD | Merck Patent GmbH (DE) | 2022-07-06 | — | — | EP | disclosed |
| EP-3440065-B1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE BERAPROST | EUROAPI HUNGARY LLC (HU) | 2022-06-08 | — | — | EP | disclosed |
| US-11168249-B1 | Luminescent polydentate polycyclic compounds for metal ions | ZAVALETA FERNANDEZ DE CORDOVA ANDRES (US) | 2021-11-09 | — | — | US | disclosed |
| EP-3862354-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2021-08-11 | — | — | EP | disclosed |
| US-11021445-B2 | Carboxylic acid derivative as AT2R receptor antagonist | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2021-06-01 | — | — | US | disclosed |
| EP-3620454-B1 | CARBOXYLIC ACID DERIVATIVE AS AT2R RECEPTOR ANTAGONIST | SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) | 2021-05-05 | — | — | EP | disclosed |
| WO-2021037362-A1 | OPTIMIZED ANALYTE DERIVATIZATION FOR SYNERGISTIC APPLICATION WITH CRYSTAL SPONGE METHOD | MERCK PATENT GMBH (DE) | 2021-03-04 | — | — | WO | disclosed |
| WO-2021037937-A1 | OPTIMIZED ANALYTE DERIVATIZATION FOR SYNERGISTIC APPLICATION WITH CRYSTAL SPONGE METHOD | MERCK PATENT GMBH (DE) | 2021-03-04 | — | — | WO | disclosed |
| EP-3786623-A1 | OPTIMIZED ANALYTE DERIVATIZATION FOR SYNERGISTIC APPLICATION WITH CRYSTAL SPONGE METHOD | Merck Patent GmbH (DE) | 2021-03-03 | — | — | EP | disclosed |
| US-20200231562-A1 | NOVEL MACROLIDE ANTIBIOTICS | LEIBNIZ-INSTITUT FÜR NATURSTOFF-FORSCHUNG UND INFEKTIONSBIOLOGIE E.V. (HKI) (DE) | 2020-07-23 | — | — | US | disclosed |
| US-10633586-B1 | Luminescent polydentate polycyclic compounds for metal ions | ZAVALETA FERNANDEZ DE CORDOVA ANDRES (US) | 2020-04-28 | — | — | US | disclosed |
| WO-2020067684-A1 | NOVEL METHOD FOR PREPARING (-)-CIBENZOLINE SUCCINATE | (주)셀트리온 | 2020-04-02 | — | — | WO | disclosed |
| US-20200102275-A1 | CARBOXYLIC ACID DERIVATIVE AS AT2R RECEPTOR ANTAGONIST | SHANDONG DANHONG PHARMACEUTICAL CO., LTD. | 2020-04-02 | — | — | US | disclosed |
| US-10421737-B2 | Process for the preparation of optically active Beraprost | CHINOIN PHARMACEUTICAL AND CHEMICAL WORKS PRIVATE COMPANY LTD. (HU) | 2019-09-24 | — | — | US | disclosed |
| EP-3080121-B1 | FUSED TRICYCLIC BENZIMIDAZOLES DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2019-09-04 | — | — | EP | disclosed |
| EP-3140265-B1 | PROCESS FOR OBTAINING OPTICALLY ACTIVE PIRLINDOLE ENANTIOMERS AND SALTS THEREOF | TECNIMEDE SOCIEDADE TECNICO MEDICINAL S (PT) | 2019-08-28 | — | — | EP | disclosed |
| EP-3273936-B1 | PEARLY LUSTER CONCENTRATES IN AQUEOUS MEDIA CONTAINING SURFACTANTS | BASF SE (DE) | 2019-05-08 | — | — | EP | disclosed |
| US-10259779-B2 | Structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity | WAYNE STATE UNIVERSITY (US) | 2019-04-16 | — | — | US | disclosed |
| EP-3440065-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE BERAPROST | Chinoin Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) | 2019-02-13 | — | — | EP | disclosed |
| US-10125074-B2 | 5-substituted-5-hydroxy-5-aryl-3-oxo-pentanoate derivatives and their enantiopure forms | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2018-11-13 | — | — | US | disclosed |
| EP-3166934-B1 | NOVEL MACROLIDE ANTIBIOTICS | HELMHOLTZ ZENTRUM INFEKTIONSFORSCHUNG GMBH (DE) | 2018-05-23 | — | — | EP | disclosed |
| US-9962377-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | TAKEDA GMBH (DE) | 2018-05-08 | — | — | US | disclosed |
| US-20180118648-A1 | 5-SUBSTITUTED-5-HYDROXY-5-ARYL-3-OXO-PENTANOATE DERIVATIVES AND THEIR ENANTIOPURE FORMS | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2018-05-03 | — | — | US | disclosed |
| US-20180057448-A1 | Structural requirements of histone deacetylase inhibitors: C4-modified saha analogs display dual HDAC6/HDAC8 selectivity | WAYNE STATE UNIVERSITY | 2018-03-01 | — | — | US | disclosed |
| US-9823199-B1 | Luminescent polydentate polycyclic compounds for metal ions | Zavaleta Fernandez de Cordova, Andres Nildo (US) | 2017-11-21 | — | — | US | disclosed |
| WO-2017174439-A1 | PROCESS FOR THE PREPARATION OF OPTICALLY ACTIVE BERAPROST | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. (HU) | 2017-10-12 | — | — | WO | disclosed |
| EP-3191464-A1 | SYNTHESIS OF ISOFLAVANES AND INTERMEDIATES THEREOF | System Biologie AG (CH) | 2017-07-19 | — | — | EP | disclosed |
| EP-3166934-A1 | NOVEL MACROLIDE ANTIBIOTICS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2017-05-17 | — | — | EP | disclosed |
| EP-3080121-A1 | FUSED TRICYCLIC BENZIMIDAZOLES DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB Biopharma SPRL (BE) | 2016-10-19 | — | — | EP | disclosed |
| EP-2268640-B1 | PROCESS FOR PREPARING ENANTIOMERICALLY PURE INDOLOPYRIDINES | 4SC AG (DE) | 2016-10-12 | — | — | EP | disclosed |
| US-20160279120-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | TAKEDA GMBH (DE) | 2016-09-29 | — | — | US | disclosed |
| WO-2016151990-A1 | 5-SUBSTITUTED-5-HYDROXY-5-ARYL-3-OXO-PENTANOATE DERIVATIVES AND THEIR ENANTIOPURE FORMS | OKINAWA INSTITUTE OF SCIENCE AND TECHNOLOGY SCHOOL CORPORATION (JP) | 2016-09-29 | — | — | WO | disclosed |
| US-9387205-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | TAKEDA GMBH (DE) | 2016-07-12 | — | — | US | disclosed |
| US-20160185729-A1 | PROCESSES FOR PREPARING 3-BENZAZEPINES | ARENA PHARMACEUTICALS, INC. | 2016-06-30 | — | — | US | disclosed |
| WO-2016038061-A1 | SYNTHESIS OF ISOFLAVANES AND INTERMEDIATES THEREOF | SYSTEM BIOLOGIE AG (CH) | 2016-03-17 | — | — | WO | disclosed |
| EP-2332921-B1 | 8-Chloro-1 -methyl-2,3,4,5-tetrahydro-1 H-3benzazapine Hydrochloride | ARENA PHARM INC (US) | 2016-03-02 | — | — | EP | disclosed |
| WO-2016005049-A1 | NOVEL MACROLIDE ANTIBIOTICS | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2016-01-14 | — | — | WO | disclosed |
| US-20150352096-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-12-10 | — | — | US | disclosed |
| US-9149479-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | TAKEDA GMBH (DE) | 2015-10-06 | — | — | US | disclosed |
| US-9102627-B2 | Processes for preparing 3-benzazepines | ARENA PHARMACEUTICALS, INC. | 2015-08-11 | — | — | US | disclosed |
| WO-2015086525-A1 | FUSED TRICYCLIC BENZIMIDAZOLES DERIVATIVES AS MODULATORS OF TNF ACTIVITY | UCB BIOPHARMA SPRL (BE) | 2015-06-18 | — | — | WO | disclosed |
| US-20150119389-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2015-04-30 | — | — | US | disclosed |
| US-8946207-B2 | Processes for preparing 3-benzazepines | ARENA PHARMACEUTICALS, INC. (US) | 2015-02-03 | — | — | US | disclosed |
| EP-2824105-A1 | Indolopyridines as Eg5 kinesin modulators | 4SC AG (DE) | 2015-01-14 | — | — | EP | disclosed |
| US-8883818-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | TAKEDA GMBH (DE) | 2014-11-11 | — | — | US | disclosed |
| EP-2589599-B1 | Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | TAKEDA GMBH (DE) | 2014-06-25 | — | — | EP | disclosed |
| US-20140073636-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | TAKEDA GMBH (DE) | 2014-03-13 | — | — | US | disclosed |
| US-8653283-B2 | Anticancer agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2014-02-18 | — | — | US | disclosed |
| EP-2189448-B1 | Processes for the Separation of 3-Benzazepine Racemates | ARENA PHARM INC (US) | 2014-01-29 | — | — | EP | disclosed |
| US-8557991-B2 | Process for preparing enantiomerically pure indolopyridines | 4SC AG (DE) | 2013-10-15 | — | — | US | disclosed |
| EP-2331545-B1 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE&NEW IMPURITIES IN PREPARATION THEREOF | CADILA HEALTHCARE LTD (IN) | 2013-10-02 | — | — | EP | disclosed |
| US-8530493-B2 | Indolopyridines as Eg5 kinesin modulators | 4SC AG (DE) | 2013-09-10 | — | — | US | disclosed |
| US-20130178620-A1 | PROCESSES FOR PREPARING 3-BENZAZEPINES | ARENA PHARMACEUTICALS, INC. | 2013-07-11 | — | — | US | disclosed |
| US-8476437-B2 | Process for preparation of (2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro [1,2,4]-triazolo[4,3-a]pyrazin-7(8H)-yl]-l-(2,4,5-trifluorophenyl)butan-2-amine and new impurities in preparation thereof | CADILA HEALTHCARE LIMITED (IN) | 2013-07-02 | — | — | US | disclosed |
| US-20130165648-A1 | PROCESSES FOR PREPARING 3-BENZAZEPINES | ARENA PHARMACEUTICALS, INC. | 2013-06-27 | — | — | US | disclosed |
| EP-1723135-B1 | NOVEL HYDROXY-6-HEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | TAKEDA GMBH (DE) | 2013-06-19 | — | — | EP | disclosed |
| US-8455653-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | TAKEDA GMBH (DE) | 2013-06-04 | — | — | US | disclosed |
| WO-2013065066-A1 | PROCESSES FOR PREPARING 4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6- DIHYDRO [L,2,41-TRIAZOLO[43-A]PYRAZIN-7(8H)-YL]-L-(2,4,5- TRIFLUOROPHENYL)BUTAN-2-AMINE | CADILA HEALTHCARE LIMITED (IN) | 2013-05-10 | — | — | WO | disclosed |
| EP-2589599-A1 | Novel hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | Takeda GmbH (DE) | 2013-05-08 | — | — | EP | disclosed |
| US-20130045974-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | NYCOMED GMBH (DE) | 2013-02-21 | — | — | US | disclosed |
| US-8367657-B2 | Processes for preparing 3-benzazepines | ARENA PHARMACEUTICALS, INC. (US) | 2013-02-05 | — | — | US | disclosed |
| EP-1720835-B1 | NOVEL GUANIDINYL-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AS EFFECTIVE PHOSPHODIESTERASE (PDE) 4 INHIBITORS | NYCOMED GMBH (DE) | 2012-12-12 | — | — | EP | disclosed |
| US-8329906-B2 | Guanidinyl-substituted hydroxy-6-phenylphenanthridines | NYCOMED GMBH (DE) | 2012-12-11 | — | — | US | disclosed |
| US-8324391-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | NYCOMED GMBH (DE) | 2012-12-04 | — | — | US | disclosed |
| US-8318944-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | NYCOMED GMBH (DE) | 2012-11-27 | — | — | US | disclosed |
| US-8202880-B2 | 3-hydroxy-6-phenylphenanthridines as PDE4 inhibitors | NYCOMED GMBH (DE) | 2012-06-19 | — | — | US | disclosed |
| EP-1598337-B1 | METHOD OF OBTAINING AN ANTIEPILEPTIC AGENT | ESTEVE QUIMICA SA (ES) | 2012-05-09 | — | — | EP | disclosed |
| US-20120083527-A1 | Anticancer Agents | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2012-04-05 | — | — | US | disclosed |
| US-20110257169-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | NYCOMED GMBH (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20110257221-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | NYCOMED GMBH (DE) | 2011-10-20 | — | — | US | disclosed |
| US-20110213149-A1 | PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE & NEW IMPURITIES IN PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2011-09-01 | — | — | US | disclosed |
| US-8003798-B2 | Hydroxy-6-heteroarylphenanthridines and their use as PDE4 inhibitors | NYCOMED GMBH (DE) | 2011-08-23 | — | — | US | disclosed |
| EP-2332919-A2 | Processes for preparing 3-benzazepines | Arena Pharmaceuticals, Inc. (US) | 2011-06-15 | — | — | EP | disclosed |
| EP-2332920-A2 | Processes for preparing 3-benzazepines | Arena Pharmaceuticals, Inc. (US) | 2011-06-15 | — | — | EP | disclosed |
| EP-2332921-A1 | Processes for the Separation of 3-Benzazepine Racemates | Arena Pharmaceuticals, Inc. (US) | 2011-06-15 | — | — | EP | disclosed |
| EP-2331545-A2 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE&NEW IMPURITIES IN PREPARATION THEREOF | Cadila Healthcare Limited (IN) | 2011-06-15 | — | — | EP | disclosed |
| US-20110077404-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY PURE INDOLOPYRIDINES | 4SC AG (DE) | 2011-03-31 | — | — | US | disclosed |
| US-7893268-B2 | Epithiolone analogues | UNIVERSITY OF TOLEDO (US) | 2011-02-22 | — | — | US | disclosed |
| US-20110027226-A1 | INDOLOPYRIDINES AS INHIBITORS OF THE KINESIN SPINDLE PROTEIN (EG5) | 4SC AG (DE) | 2011-02-03 | — | — | US | disclosed |
| US-20100285149-A1 | NOVEL TETRAHYDROPYRIDOTHIOPHENES | 4SC AG (DE) | 2010-11-11 | — | — | US | disclosed |
| EP-2189448-A1 | Processes for the Separation of 3-Benzazepine Racemates | Arena Pharmaceuticals, Inc. (US) | 2010-05-26 | — | — | EP | disclosed |
| US-20100104659-A1 | BENZOPYRANOPYRAZOLES | 4SC AG (DE) | 2010-04-29 | — | — | US | disclosed |
| EP-2178875-A1 | INDOLOPYRIDINES AS INHIBITORS OF THE KINESIN SPINDLE PROTEIN (EG5 ) | 4SC AG (DE) | 2010-04-28 | — | — | EP | disclosed |
| WO-2010032264-A2 | IMPROVED PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE & NEW IMPURITIES IN PREPARATION THEREOF | CADILA HEALTHCARE LIMITED (IN) | 2010-03-25 | — | — | WO | disclosed |
| EP-1846390-B1 | NOVEL 6-PYRIDYLPHENANTHRIDINES | NYCOMED GMBH (DE) | 2010-03-17 | — | — | EP | disclosed |
| US-20100035913-A1 | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiestrase (PDE) 4 inhibitors | NYCOMED GMBH (DE) | 2010-02-11 | — | — | US | disclosed |
| US-7632844-B2 | 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors | NYCOMED GMBH (DE) | 2009-12-15 | — | — | US | disclosed |
| US-20090258904-A1 | Epithiolone Analogues | UNIVERSITY OF TOLEDO | 2009-10-15 | — | — | US | disclosed |
| US-20090246169-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | NYCOMED GMBH (DE) | 2009-10-01 | — | — | US | disclosed |
| US-20090233902-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2009-09-17 | — | — | US | disclosed |
| US-7585872-B2 | Guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (PDE) 4 inhibitors | NYCOMED GMBH (DE) | 2009-09-08 | — | — | US | disclosed |
| US-20090170892-A1 | 3-Hydroxy-6-phenylphenanthridines as pde4 inhibitors | NYCOMED GMBH (DE) | 2009-07-02 | — | — | US | disclosed |
| WO-2009074677-A2 | PYRAZOLOTRIAZINES | 4SC AG (DE) | 2009-06-18 | — | — | WO | disclosed |
| EP-2070932-A1 | Pyrazolotriazines | 4SC AG (DE) | 2009-06-17 | — | — | EP | disclosed |
| EP-2051983-A1 | NTETRAHYDROPYRIDOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF CANCER | 4SC AG (DE) | 2009-04-29 | — | — | EP | disclosed |
| EP-2041141-A2 | BENZOPYRANOPYRAZOLES | 4SC AG (DE) | 2009-04-01 | — | — | EP | disclosed |
| EP-2035426-A1 | PYRAZOLOPYRIMIDONES | 4SC AG (DE) | 2009-03-18 | — | — | EP | disclosed |
| EP-2033962-A1 | Tetracyclic indolopyridines as EG5 inhibitors | 4SC AG (DE) | 2009-03-11 | — | — | EP | disclosed |
| WO-2009024613-A1 | TETRACYCLIC INDOLOPYRIDINES AS EG5 INHIBITORS | 4SC AG (DE) | 2009-02-26 | — | — | WO | disclosed |
| WO-2009024190-A1 | INDOLOPYRIDINES AS INHIBITORS OF THE KINESIN SPINDLE PROTEIN (EG5 ) | 4SC AG (DE) | 2009-02-26 | — | — | WO | disclosed |
| US-20080319067-A1 | 2-Hydroxy-6-phenylphenanthridines as PDE-4 inhibitors | NYCOMED GMBH | 2008-12-25 | — | — | US | disclosed |
| EP-1996592-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | Nycomed GmbH (DE) | 2008-12-03 | — | — | EP | disclosed |
| EP-1994033-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2008-11-26 | — | — | EP | disclosed |
| US-7423046-B2 | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors | NYCOMED GMBH (DE) | 2008-09-09 | — | — | US | disclosed |
| US-20080214536-A1 | Amido-Substituted 6-Phenylphenanthridines | NYCOMED GMBH (DE) | 2008-09-04 | — | — | US | disclosed |
| US-20080167316-A1 | 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory Disorders | ALTANA PHARMA AG (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080167301-A1 | Respiratory system disorders | ALTANA PHARMA AG (DE) | 2008-07-10 | — | — | US | disclosed |
| US-20080161339-A1 | Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors | ALTANA PHARMA AG (DE) | 2008-07-03 | — | — | US | disclosed |
| US-20080119505-A1 | Novel 6-Pyridylphenanthridines | ALTANA PHARMA AG (DE) | 2008-05-22 | — | — | US | disclosed |
| EP-1250325-B1 | PHENANTHRIDINE-N-OXIDES | NYCOMED GMBH (DE) | 2008-05-07 | — | — | EP | disclosed |
| US-20080045502-A1 | Processes for Preparing 3-Benzazepines | ARENA PHARMACEUTICALS, INC. (US) | 2008-02-21 | — | — | US | disclosed |
| WO-2008020024-A1 | NTETRAHYDROPYRIDOTHIOPHENE DERIVATIVES FOR THE TREATMENT OF CANCER | 4SC AG (DE) | 2008-02-21 | — | — | WO | disclosed |
| US-7329676-B2 | 2-hydroxy-6-phenylphenanthridines as PDE-4 inhibitors | NYCOMED GMBH (DE) | 2008-02-12 | — | — | US | disclosed |
| WO-2008006883-A2 | BENZOPYRANOPYRAZOLES | 4SC AG (DE) | 2008-01-17 | — | — | WO | disclosed |
| WO-2007144384-A1 | PYRAZOLOPYRIMIDONES | 4SC AG (DE) | 2007-12-21 | — | — | WO | disclosed |
| EP-1858880-A1 | AMIDO-SUBSTITUTED 6-PHENYLPHENANTHRIDINES | Nycomed GmbH (DE) | 2007-11-28 | — | — | EP | disclosed |
| EP-1856092-A1 | 6-HETEROARYL-1,2,3,4,4A,10B-HEXAHYDRO-PHENANTHRIDINES AS PDE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | Nycomed GmbH (DE) | 2007-11-21 | — | — | EP | disclosed |
| US-20070259909-A1 | Novel Difluoroethoxy-Substituted Hydroxy-6-Phenylphenanthridines and Their Use as Pde4 Inhibitors | ALTANA PHARMA AG (DE) | 2007-11-08 | — | — | US | disclosed |
| US-7291746-B2 | Process for obtaining an antiepileptic agent | ESTEVE QUIMICA, S.A. (ES) | 2007-11-06 | — | — | US | disclosed |
| WO-2007096395-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007096393-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | 4SC AG (DE) | 2007-08-30 | — | — | WO | disclosed |
| US-20070191414-A1 | Novel isoamido-substituted hydroxy-6-phenylphenanthridines | ALTANA PHARMA AG (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070191413-A1 | Novel heterocycle-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors | ATLANTA PHARMA AG (DE) | 2007-08-16 | — | — | US | disclosed |
| US-20070185149-A1 | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors | ALTANA PHARMA AG (DE) | 2007-08-09 | — | — | US | disclosed |
| EP-1812400-A1 | NOVEL HETEROCYCLYL-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | Altana Pharma AG (DE) | 2007-08-01 | — | — | EP | disclosed |
| US-20070167482-A1 | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors | ALTANA PHARMA AG (DE) | 2007-07-19 | — | — | US | disclosed |
| EP-1163226-B1 | POLYSUBSTITUTED 6-PHENYLPHENANTHRIDINES WITH PDE-IV INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2007-03-14 | — | — | EP | disclosed |
| WO-2007015929-A2 | EPOTHILONE ANALOGUES | UNIVERSITY OF TOLEDO (US) | 2007-02-08 | — | — | WO | disclosed |
| EP-1745025-A2 | NOVEL ISOAMIDO-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | Altana Pharma AG (DE) | 2007-01-24 | — | — | EP | disclosed |
| EP-1539164-B1 | 2-HYDROXY-6-PHENYLPHENANTHRIDINES AS PDE-4 INHIBITORS | ALTANA PHARMA AG (DE) | 2006-12-20 | — | — | EP | disclosed |
| EP-1725533-A1 | NOVEL THIO CONTAINING HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | Altana Pharma AG (DE) | 2006-11-29 | — | — | EP | disclosed |
| EP-1723135-A1 | NOVEL HYDROXY-6-HEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | Altana Pharma AG (DE) | 2006-11-22 | — | — | EP | disclosed |
| WO-2006095009-A1 | AMIDO-SUBSTITUTED 6-PHENYLPHENANTHRIDINES | NYCOMED GMBH (DE) | 2006-09-14 | — | — | WO | disclosed |
| WO-2006092417-A1 | 6 -HETEROARYL-1, 2, 3,4,4A, 1OB-HEXAHYDRO-PHENANTHRIDINES AS PDE-4 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | NYCOMED GMBH (DE) | 2006-09-08 | — | — | WO | disclosed |
| US-20060189645-A1 | Novel 6-phenylphenantridines | ALTANA PHARMA AG (DE) | 2006-08-24 | — | — | US | disclosed |
| US-20060142376-A1 | Method for obtaining an antiepileptic agent | ESTEVE QUIMICA, S.A. (ES) | 2006-06-29 | — | — | US | disclosed |
| US-20060116518-A1 | Novel phenanthridines | ALTANA PHARMA AG (DE) | 2006-06-01 | — | — | US | disclosed |
| EP-1650193-A2 | 6-Phenylphenanthridines with PDE-IV inhibiting activity | ALTANA Pharma AG (DE) | 2006-04-26 | — | — | EP | disclosed |
| EP-1147089-B1 | PHENYLPHENANTHRIDINES WITH PDE-IV INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2005-12-07 | — | — | EP | disclosed |
| EP-1598337-A1 | METHOD OF OBTAINING AN ANTIEPILEPTIC AGENT | Farma-Lepori S.A. (ES) | 2005-11-23 | — | — | EP | disclosed |
| US-20050239818-A1 | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors | ALANA PHARMA AG (DE) | 2005-10-27 | — | — | US | disclosed |
| US-20050239817-A1 | 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors | ALTANA PHARMA AG (DE) | 2005-10-27 | — | — | US | disclosed |
| WO-2005090311-A1 | NOVEL HETEROCYCLYL-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | ALTANA PHARMA AG (DE) | 2005-09-29 | — | — | WO | disclosed |
| WO-2005087744-A1 | NOVEL THIO-CONTAINING HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | ALTANA PHARMA AG (DE) | 2005-09-22 | — | — | WO | disclosed |
| WO-2005085225-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | ALTANA PHARMA AG (DE) | 2005-09-15 | — | — | WO | disclosed |
| WO-2005084104-A2 | NOVEL ISOAMIDO-SUBSTITUTED HYDROXY-6-PHENYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | ALTANA PHARMA AG (DE) | 2005-09-15 | — | — | WO | disclosed |
| US-20050153358-A1 | High-throughput screening method for determining the enantioselectivity of catalysts, biocatalysts, and agents | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2005-07-14 | — | — | US | disclosed |
| US-20050154051-A1 | Method for the preparation of escitalopram | H. LUNDBECK A/S (DK) | 2005-07-14 | — | — | US | disclosed |
| EP-1147087-B1 | PHENANTHRIDINE-N-OXIDES WITH PDE-IV INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2005-05-11 | — | — | EP | disclosed |
| EP-1147103-B1 | PHENANTRHRIDINE-N-OXIDES WITH PDE-IV INHIBITING ACTIVITY | ALTANA PHARMA AG (DE) | 2005-05-04 | — | — | EP | disclosed |
| US-6884802-B2 | 6-heteroarylphenanthridines | ALTANA PHARMA AG (DE) | 2005-04-26 | — | — | US | disclosed |
| EP-1458701-A1 | METHOD FOR THE PREPARATION OF ESCITALOPRAM | H. Lundbeck A/S (DK) | 2004-09-22 | — | — | EP | disclosed |
| US-20040038979-A1 | Treating airway disorders such as asthma. | ALTANA PHARMA AG (DE) | 2004-02-26 | — | — | US | disclosed |
| US-6630483-B2 | Phenanthridine-N-oxides | ALTANA PHARMA AG (DE) | 2003-10-07 | — | — | US | disclosed |
| WO-2003051861-A1 | METHOD FOR THE PREPARATION OF ESCITALOPRAM | H. LUNDBECK A/S (DK) | 2003-06-26 | — | — | WO | disclosed |
| US-20030105123-A1 | For therapy of respiratory system disorders | ALTANA PHARMA AG (DE) | 2003-06-05 | — | — | US | disclosed |
| US-6538005-B2 | As inhibitors of phosphodiesterases; therapy | ALTANA PHARMA AG (DE) | 2003-03-25 | — | — | US | disclosed |
| US-6534519-B1 | Phosphodiestease inhibitors are novel active bronchial therapeutics. | ALTANA PHARMA AG (DE) | 2003-03-18 | — | — | US | disclosed |
| US-6534518-B1 | Phosphodiesterase inhibitors for respiratory system disorders | ALTANA PHARMA AG (DE) | 2003-03-18 | — | — | US | disclosed |
| EP-0872467-B1 | Process for the production of chiral unsaturated alcohols in high optical purity | EASTMAN CHEM CO (US) | 2003-01-22 | — | — | EP | disclosed |
| US-20020183350-A1 | Phenanthridine-n-oxides with pde-iv inhibiting activity | GUTTERER BEATE (DE) | 2002-12-05 | — | — | US | disclosed |
| US-6479505-B1 | TREATING AIRWAY DISORDER IN A PATIENT COMPRISING ADMINISTERING TO SAID PATIENT IN NEED THEREOF A THERAPEUTICALLY EFFECTIVE AMOUNT OF A PHOSPHODIESTERASE IV INHIBITOR | ALTANA PHARMA AG (DE) | 2002-11-12 | — | — | US | disclosed |
| US-6476025-B1 | Phenylphennanthridines with PDE-IV inhibiting activity | ALTANA PHARMA AG (DE) | 2002-11-05 | — | — | US | disclosed |
| US-6414049-B1 | SILICONE, ACYLPHOSPHINE PROMOTER, ACID MIXTURE | JOHNSON & JOHNSON VISION CARE, INC. | 2002-07-02 | — | — | US | disclosed |
| WO-2002006238-A1 | CYCLOALKYL - OR CYCLOALKYLMETHYL-SUBSTITUTED 6-PHENYLPHENANTHRIDINES | ALTANA PHARMA AG (DE) | 2002-01-24 | — | — | WO | disclosed |
| EP-0754696-B1 | Unsymmetric diphosphine monoxide compounds and a process for preparing diphosphine compounds | TAKASAGO PERFUMERY CO LTD (JP) | 2002-01-16 | — | — | EP | disclosed |
| US-6162943-A | BY REACTING A KETO ESTER WITH TRIFLUOROMETHYLTRIMETHYL SILANE TO FORM A-TRIMETHYLSILOXY-A-TRIFLUOROMETHYL ARYL ACETIC ESTER; REACTING WITH ALKOXIDE TO FORM METAL SALT, AND ALKYLATING; REAGENT FOR DETERMINING OPTICAL PURITY OF AMINES | BAYER AKTIENGESELLSCHAFT (DE) | 2000-12-19 | — | — | US | disclosed |
| US-6093345-A | PYRIMIDINE COMPOUNDS, ELECTROOPTICS | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2000-07-25 | — | — | US | disclosed |
| EP-0993436-A1 | (S) 2-METHYLAMINO-2-PHENYL-$i(n)-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN | PARKE-DAVIS (FR) | 2000-04-19 | — | — | EP | disclosed |
| US-5968938-A | Piperazine oxytocin receptor antagonists | MERCK & CO., INC. (US) | 1999-10-19 | — | — | US | disclosed |
| US-5886214-A | CATALYTIC ASYMMETRIC HYDROGENATION OF ENOL ESTERS BEARING A VINYLLIC OR AN ACETYLENIC SUBSTITUENT BY USING A CHIRAL RHODIUM(I) HYDROGENATION CATALYST PREPARED FROM A SUITABLE RHODIUM SALT AND AN OPTICALLY PURE PHOSPHINE LIGAND | EASTMAN CHEMICAL COMPANY (US) | 1999-03-23 | — | — | US | disclosed |
| WO-1999001417-A1 | (S) 2-METHYLAMINO-2-PHENYL-n-BUTYL 3,4,5-TRIMETHOXYBENZOATE, ITS APPLICATION TO THE TREATMENT OF CHRONIC PAIN | PARKE-DAVIS (FR) | 1999-01-14 | — | — | WO | disclosed |
| EP-0872467-A1 | Process for the production of chiral unsaturated alcohols in high optical purity | EASTMAN CHEMICAL COMPANY (US) | 1998-10-21 | — | — | EP | disclosed |
| US-5808162-A | Chiral unsymmetric diphosphine compound and transition metal complex containing the same as ligand | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-09-15 | — | — | US | disclosed |
| US-5712388-A | Method of preparing a derivative of optically active azetidin-2-one | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1998-01-27 | — | — | US | disclosed |
| EP-0788472-A1 | A PROCESS FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | CHIESI FARMACEUTICI S.p.A. (IT) | 1997-08-13 | — | — | EP | disclosed |
| EP-0754696-A1 | Chiral unsymmetric diphosphine compounds and transition metal complexes containing them as ligands | Takasago International Corporation (JP) | 1997-01-22 | — | — | EP | disclosed |
| EP-0427168-B1 | Optical isomer of triazolylpentenols, and their production and use as fungicide, herbicide and/or plant growth regulant | SUMITOMO CHEMICAL CO (JP) | 1996-03-13 | — | — | EP | disclosed |
| EP-0255379-B1 | Optically active alcohols, process for producing the same, and process for resolving the same | NISSAN CHEMICAL IND LTD (JP) | 1995-11-15 | — | — | EP | disclosed |
| WO-1995029147-A1 | A PROCESS FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES | CHIESI FARMACEUTICI S.P.A. (IT) | 1995-11-02 | — | — | WO | disclosed |
| US-5454976-A | Optical active mixture comprising a fluoro-alkyl phenyl pyrimidine compounds; high contrast ratio, fast response time; optical switches, printer shutter arrays | TAKASAGO INTERNATIONAL CORPORATION (JP) | 1995-10-03 | — | — | US | disclosed |
| US-5428171-A | Leukotrienes antagonist; antiasthmatic, antiallergic, anti-inflammatory and cytoprotective agent | MERCK FROSST CANADA, INC. (CA) | 1995-06-27 | — | — | US | disclosed |
| US-5348980-A | Antihistamines, antiallergens | INSTITUTE DE RECHERCHE JOUVEINAL (FR) | 1994-09-20 | — | — | US | disclosed |
| US-5344936-A | Selenocarbonyloxazolidinone | UNIVERSITY OF SOUTH CAROLINA (US) | 1994-09-06 | — | — | US | disclosed |
| US-5342780-A | Methods of enzymatically separating stereoisomers of a racemic mixture of a reactive ester | UNIVERSITY OF NEW MEXICO (US) | 1994-08-30 | — | — | US | disclosed |
| EP-0354068-B1 | Optically active piperazine derivative | NIPPON CHEMIPHAR CO (JP) | 1994-06-15 | — | — | EP | disclosed |
| US-5175378-A | Synthesis of optically pure forms of ipsdienol | ALDRICH CHEMICAL COMPANY, INC. (US) | 1992-12-29 | — | — | US | disclosed |
| US-5175371-A | Synthesis of optically pure forms of ipsenol | ALDRICH CHEMICAL COMPANY, INC. (US) | 1992-12-29 | — | — | US | disclosed |
| US-5136034-A | Reacting an arylaldehyde with mercaptan and thioacyl in presence of acid catalysts; then reacting with electrophile | MERCK FROSST CANADA, INC. (CA) | 1992-08-04 | — | — | US | disclosed |
| US-5122472-A | Selenocarbonyl compound as coupler in determination of enantiomeric purity | UNIVERSITY OF SOUTH CAROLINA (US) | 1992-06-16 | — | — | US | disclosed |
| US-5103063-A | Intermediates useful for the chiral isoprenylation of aldehydes | ALDRICH CHEMICAL COMPANY, INC. (US) | 1992-04-07 | — | — | US | disclosed |
| EP-0121284-B1 | (+)-TRIAZOLYLPENTENOL DERIVATIVE, ITS PRODUCTION AND USE AS HERBICIDE AND/OR PLANT GROWTH REGULANT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1992-03-11 | — | — | EP | disclosed |
| US-5075488-A | Fungicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-12-24 | — | — | US | disclosed |
| EP-0128006-B1 | A SOIL-DISEASE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-09-18 | — | — | EP | disclosed |
| US-5041559-A | Having epoxy and silyl groups | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1991-08-20 | — | — | US | disclosed |
| US-5037855-A | Silane group containing, chemical intermediates | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1991-08-06 | — | — | US | disclosed |
| EP-0427168-A1 | Optical isomer of triazolylpentenols, and their production and use as fungicide, herbicide and/or plant growth regulant | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-05-15 | — | — | EP | disclosed |
| EP-0421774-A2 | Process for production of optically active 2-(tetrahydropyran-2-yloxy)-1-propanol | Takasago International Corporation (JP) | 1991-04-10 | — | — | EP | disclosed |
| US-4987236-A | STEREOSPECIFIC EPOXIDATION, RESOLUTION OF RACEMIC MIXTURES | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1991-01-22 | — | — | US | disclosed |
| US-4978666-A | INCREASED CEREBRAL CIRCULATION; ANTICOAGULANTS | NIPPON CHEMIPHAR CO., LTD. (JP) | 1990-12-18 | — | — | US | disclosed |
| US-4954625-A | ENZYME INHIBITORS, HYPOTENSIVE AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1990-09-04 | — | — | US | disclosed |
| US-4902812-A | Optically active alcohols, process for producing the same, and process for resolving the same | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 1990-02-20 | — | — | US | disclosed |
| US-4871842-A | Piperidine derivatives | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-10-03 | — | — | US | disclosed |
| US-4851409-A | LEUKOTRIENE ANTAGONIST, ANTIASTHMA, ANTIALLERGEN, ANTIINFLAMMATORY, CYTOPROTECTIVE | MERCK FROSST CANADA INC. (CA) | 1989-07-25 | — | — | US | disclosed |
| US-4816466-A | HYPOTENSIVE AGENTS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1989-03-28 | — | — | US | disclosed |
| US-4730065-A | BRONCHODILATORS, HYPOTENSIVES, ANTISECRETORY | AMERICAN CYANAMID COMPANY (US) | 1988-03-08 | — | — | US | disclosed |
| EP-0255379-A2 | Optically active alcohols, process for producing the same, and process for resolving the same | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1988-02-03 | — | — | EP | disclosed |
| EP-0233763-A2 | 2-Substituted quinoline dioic acids | MERCK FROSST CANADA INC. (CA) | 1987-08-26 | — | — | EP | disclosed |
| EP-0054431-B1 | OPTICAL ISOMER OF A TRIAZOLYLPENTENOL, AND ITS PRODUCTION AND USE AS FUNGICIDE | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-03-04 | — | — | EP | disclosed |
| EP-0187037-A2 | Piperidine derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1986-07-09 | — | — | EP | disclosed |
| EP-0175278-A2 | Optical isomer of triazolylpentenols, and their production and use as fungicide herbicide and/or plant growth regulant | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1986-03-26 | — | — | EP | disclosed |
| US-4518790-A | 15-Deoxy-16-hydroxy-16-vinyl and cyclopropyl substituted prostanoic acids and congeners | AMERICAN CYANAMID COMPANY (US) | 1985-05-21 | — | — | US | disclosed |
| US-4504417-A | 15-Deoxy-16-hydroxy-16-substituted prostanoic acids and congeners | AMERICAN CYANAMID COMPANY (US) | 1985-03-12 | — | — | US | disclosed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | disclosed |
| EP-0121284-A2 | (+)-Triazolylpentenol derivative, its production and use as herbicide and/or plant growth regulant | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-10-10 | — | — | EP | disclosed |
| US-4473502-A | Synthesis of thienamycin via (3SR, 4RS)-3-[1 (SR)-hydroxyethyl]-2-oxo-4-azetidineacetic acid | MERCK & CO., INC. (US) | 1984-09-25 | — | — | US | disclosed |
| US-4467107-A | INTERMEDIATES FOR THIENAMYCIN | MERCK & CO., INC. (US) | 1984-08-21 | — | — | US | disclosed |
| US-4448721-A | Hydroxyvitamin D2 compounds and process for preparing same | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 1984-05-15 | — | — | US | disclosed |
| US-4435203-A | 1-(4-CHLORO- OR 2,4-DICHLORO-PHENYL)-2-(1,2,4-TRIAZOL-1-YL)-4,4-DIMETHYLPENT-1-EN-3-OL | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-03-06 | — | — | US | disclosed |
| US-4429148-A | PROSTAGLANDINS; BRONCHODILATORS, HYPTOTENSIVES | AMERICAN CYANAMID COMPANY (US) | 1984-01-31 | — | — | US | disclosed |
| US-4415746-A | BRONCHODILATORS; HYPOTENSIVE AND ANTIFERTILITY AGENTS; OXYTOCICS | AMERICAN CYANAMID COMPANY (US) | 1983-11-15 | — | — | US | disclosed |
| US-4414155-A | Synthesis of thienamycin via esters of (3SR, 4RS)-3-[(SR)-1-hydroxyethyl]-β,2-dioxo-4-azetidinebutanoic acid | MERCK & CO., INC. (US) | 1983-11-08 | — | — | US | disclosed |
| EP-0087319-A1 | R- and S-isomers of 6-chloro-7,8-dihydroxy-1-(4-hydroxyphenyl)-2,3,4,5-tetrahydro-1H-3-benzazepine | SMITHKLINE BECKMAN CORPORATION (US) | 1983-08-31 | — | — | EP | disclosed |
| US-4387241-A | BRONCHODILATORS, HYPOTENSIVE AGENTS, AND CONTRACEPTIVES | AMERICAN CYANAMID COMPANY (US) | 1983-06-07 | — | — | US | disclosed |
| US-4358605-A | BRONCHODILATORS, HYPOTENSIVE, ANTIULCER | AMERICAN CYANAMID COMPANY (US) | 1982-11-09 | — | — | US | disclosed |
| US-4349687-A | Intermediate for synthesis of thienamycin via (3SR, 4RS)-3-[1 (SR)-hydroxyethyl]-2-oxo-4-azetidineacetic acid | MERCK & CO., INC. (US) | 1982-09-14 | — | — | US | disclosed |
| EP-0054431-A1 | Optical isomer of a triazolylpentenol, and its production and use as fungicide | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1982-06-23 | — | — | EP | disclosed |
| US-4334077-A | Stereospecific sulfoxidation of dibenzo thiepins | MERCK & CO., INC. (US) | 1982-06-08 | — | — | US | disclosed |
| US-4328358-A | ENANTIOMORPHS USEFUL AS BRONCHODILATORS, HYPOTENSIVE AGENTS OR GASTRIC ANTISECRETORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1982-05-04 | — | — | US | disclosed |
| US-4321405-A | HYPOTENSIVE AGENTS, BRONCHODILATORS, ANTISECRETORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1982-03-23 | — | — | US | disclosed |
| US-4287123-A | Synthesis of thienamycin via (3SR, 4RS)-3-((RS)-1-acyloxyethyl)-2-oxo-4-azetidineacetate | MERCK & CO., INC. (US) | 1981-09-01 | — | — | US | disclosed |
| US-4282148-A | Synthesis of thienamycin via esters of (3SR, 4RS)-3-[(SR)-1-hydroxyethyl]-β,2-dioxo-4-azetidinebutanoic acid | MERCK & CO., INC. (US) | 1981-08-04 | — | — | US | disclosed |
| US-4281153-A | USEFUL AS BRONCHODILATORS, HYPOTENSIVE AGENTS AND AGENTS FOR THE CONTROL OF GASTRIC SECRETION | AMERICAN CYANAMID (US) | 1981-07-28 | — | — | US | disclosed |
| EP-0032400-A1 | (3SR, 4RS)-3-((RS)-1-hydroxyethyl)- and -((RS)-1-acyloxyethyl)-2-oxo-4-azetidineacetic acid compounds and a process for preparing the same | MERCK & CO. INC. (US) | 1981-07-22 | — | — | EP | disclosed |
| US-4245121-A | HAVING A TERMINAL CYCLIC MOIETY IN THE B-CHAIN | AMERICAN CYANAMID COMPANY (US) | 1981-01-13 | — | — | US | disclosed |
| US-4243817-A | TERMINAL CYCLIC MOIETY IN THE B-CHAIN; PROSTOGLANDIN ACTIVITY | AMERICAN CYANAMID COMPANY (US) | 1981-01-06 | — | — | US | disclosed |
| US-4239900-A | BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTISECRETORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4239899-A | BRONCHODILATORS, HYPOTENSIVE, GASTRIC ANTISECRETORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1980-12-16 | — | — | US | disclosed |
| US-4228296-A | PROSTAGLANDINS | AMERICAN CYANAMID COMPANY (US) | 1980-10-14 | — | — | US | disclosed |
| US-4219664-A | BRONCHODILATORS, HYPOTENSIVE AGENTS, GASTRIC ACID SECRETION INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1980-08-26 | — | — | US | disclosed |
| US-4202989-A | BRONCHODILATORS, HYPOTENSIVE AGENTS ANTISECRETORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1980-05-13 | — | — | US | disclosed |
| US-4202988-A | Prostenoic acids and esters | AMERICAN CYANAMID COMPANY (US) | 1980-05-13 | — | — | US | disclosed |
| US-4198521-A | BRONCHODILATOR, HYPOTENSIVE, AND ANTISECRETORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1980-04-15 | — | — | US | disclosed |
| US-4197407-A | PROSTAGLANDINS | AMERICAN CYANAMID COMPANY (US) | 1980-04-08 | — | — | US | disclosed |
| US-4194055-A | PROSTAGLANDINS, BRONCHODILATORS, ANTIINFLAMMATORY, HYPOTSENSIVE, ANTIULCER | AMERICAN CYANAMID COMPANY (US) | 1980-03-18 | — | — | US | disclosed |
| US-4192950-A | BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTISECRETORY AGENTS | AMERICAN CYANAMID COMPANY (US) | 1980-03-11 | — | — | US | disclosed |
| US-4191699-A | ANTISECRETORY, HYPOTENSIVE, BRONCHODILATOR | AMERICAN CYANAMID COMPANY (US) | 1980-03-04 | — | — | US | disclosed |
| US-4190597-A | BRONCHODILATORS, HYPOTENSIVE, ANTIULCER | AMERICAN CYANAMID COMPANY (US) | 1980-02-26 | — | — | US | disclosed |
| US-4190596-A | BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTISECRETORY, ANTIULCER | AMERICAN CYANAMID COMPANY (US) | 1980-02-26 | — | — | US | disclosed |
| US-4179451-A | HYPOTENSIVE, ANTIULCER, BRONCHODILATOR, ANTICONVULSANTS OR ANTIMICROBIAL AGENTS | AMERICAN CYANAMID COMPANY (US) | 1979-12-18 | — | — | US | disclosed |
| US-4178456-A | PROSTAGLANDINS | AMERICAN CYANAMID COMPANY (US) | 1979-12-11 | — | — | US | disclosed |
| US-4178461-A | BRONCHODILATORS, GASTRIC ACID SECRETION INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1979-12-11 | — | — | US | disclosed |
| US-4152524-A | BRONCHODILATORS, HYPOTENSIVE | AMERICAN CYANAMID COMPANY (US) | 1979-05-01 | — | — | US | disclosed |
| US-4131737-A | PROSTAGLANDINS | AMERICAN CYANAMID COMPANY (US) | 1978-12-26 | — | — | US | disclosed |
| US-4113967-A | BRONCHODILATORS, HYPOTENSIVE, ANTISECRETORY | AMERICAN CYANAMID COMPANY (US) | 1978-09-12 | — | — | US | disclosed |
| US-4111959-A | BRONCHODILATORS, ANTIINFLAMMATORY, HYPOTENSIVE, ANTISECRETORY | AMERICAN CYANAMID COMPANY (US) | 1978-09-05 | — | — | US | disclosed |
| US-4107441-A | HYPOTENSIVE, ANTIULCER, BRONCHODILATORS, ANTIMICROBIAL, ANTICONVULSANTS | AMERICAN CYANAMID COMPANY (US) | 1978-08-15 | — | — | US | disclosed |
| US-4076947-A | BRONCHODILATORS, HYPOTENSIVE AGENTS, ANTIULCER AGENTS | AMERICAN CYANAMID COMPANY (US) | 1978-02-28 | — | — | US | disclosed |
| US-4061672-A | Derivatives of 9-hydroxy-13-trans-prostenoic acid | AMERICAN CYANAMID COMPANY (US) | 1977-12-06 | — | — | US | disclosed |
| US-4061670-A | BRONCHODILATOR, HYPOTENSIVE, ANTISECRETORY | AMERICAN CYANAMID COMPANY (US) | 1977-12-06 | — | — | US | disclosed |
| US-RE29469-E | PROSTAGLANDINS; BRONCHODILATORS, HYPOTENSIVES, ANTIULCER AGENTS | AMERICAN CYANAMID COMPANY (US) | 1977-11-08 | — | — | US | disclosed |
| US-4054604-A | MICROBIOCIDES, HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1977-10-18 | — | — | US | disclosed |
| US-4044043-A | HYPERTENSIVE AGENTS, MICROBIOCIDES | AMERICAN CYANAMID COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
| US-4039574-A | 13-Hydroxy-15-deoxy-prostaglandins | AMERICAN CYANAMID COMPANY (US) | 1977-08-02 | — | — | US | disclosed |
| US-4028396-A | BRONCHODILATORS, GASTRIC ACID SECRETION INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1977-06-07 | — | — | US | disclosed |
| US-3981868-A | MICROBIOCIDES, HYPOTENSIVE AGENTS | AMERICAN CYANAMID COMPANY (US) | 1976-09-21 | — | — | US | disclosed |
| US-3950406-A | BRONCHODILATORS, HYPOTENSIVE, ANTIULCER | AMERICAN CYANAMID COMPANY (US) | 1976-04-13 | — | — | US | disclosed |
| US-3932463-A | BRONCHODILATORS, GASTRIC ACID SECRETION INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
| US-3932463-A | BRONCHODILATORS, GASTRIC ACID SECRETION INHIBITORS | AMERICAN CYANAMID COMPANY (US) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (50 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10421737-B2 | Process for the preparation of optically active Beraprost | CYP51A1, DDOST, SQLE | PDPK1 1916/4885PPARG 3219/4885PPARA 2423/4885 |
| US-20200231562-A1 | NOVEL MACROLIDE ANTIBIOTICS | MRPL21, MRPS18A, LSS | PDPK1 3428/4885PPARG 1561/4885PPARA 1997/4885 |
| US-20150352096-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE12 | PDPK1 293/4885PPARG 937/4885PPARA 2094/4885 |
| US-20080119505-A1 | Novel 6-Pyridylphenanthridines | PDE4A, PDE4B, PDE4C | PDPK1 479/4885PPARG 1583/4885PPARA 2835/4885 |
| US-20030105123-A1 | For therapy of respiratory system disorders | CHRM3, CYP11B1, CYP11B2 | PDPK1 4295/4885PPARG 737/4885PPARA 2066/4885 |
| US-20110077404-A1 | PROCESS FOR PREPARING ENANTIOMERICALLY PURE INDOLOPYRIDINES | GRIK5, CYP3A5, GRK5 | PDPK1 545/4885PPARG 3029/4885PPARA 4559/4885 |
| US-20120083527-A1 | Anticancer Agents | TP53, HCCS, RB1 | PDPK1 631/4885PPARG 1164/4885PPARA 947/4885 |
| US-20110027226-A1 | INDOLOPYRIDINES AS INHIBITORS OF THE KINESIN SPINDLE PROTEIN (EG5) | KIF5A, KIF5C, KIF5B | PDPK1 277/4885PPARG 4306/4885PPARA 4708/4885 |
| US-10259779-B2 | Structural requirements of histone deacetylase inhibitors: C4-modified SAHA analogs display dual HDAC6/HDAC8 selectivity | HDAC8, HDAC6, HDAC1 | PDPK1 3515/4885PPARG 1619/4885PPARA 1866/4885 |
| US-20140073636-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE12 | PDPK1 293/4885PPARG 937/4885PPARA 2094/4885 |
| US-20130045974-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE4C | PDPK1 89/4885PPARG 200/4885PPARA 723/4885 |
| US-20200102275-A1 | CARBOXYLIC ACID DERIVATIVE AS AT2R RECEPTOR ANTAGONIST | AGTR2, AGTR1, HCAR2 | PDPK1 2700/4885PPARG 232/4885PPARA 294/4885 |
| US-20100285149-A1 | NOVEL TETRAHYDROPYRIDOTHIOPHENES | BAX, CCAR2, BCL2 | PDPK1 1812/4885PPARG 2394/4885PPARA 3416/4885 |
| US-11021445-B2 | Carboxylic acid derivative as AT2R receptor antagonist | AGTR2, AGTR1, HCAR2 | PDPK1 2700/4885PPARG 232/4885PPARA 294/4885 |
| US-20060142376-A1 | Method for obtaining an antiepileptic agent | VKORC1, EPM2A, HNMT | PDPK1 2767/4885PPARG 3967/4885PPARA 3522/4885 |
| US-20180057448-A1 | Structural requirements of histone deacetylase inhibitors: C4-modified saha analogs display dual HDAC6/HDAC8 selectivity | HDAC8, HDAC6, HDAC1 | PDPK1 3515/4885PPARG 1619/4885PPARA 1866/4885 |
| US-20110257221-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE4C | PDPK1 206/4885PPARG 529/4885PPARA 1691/4885 |
| US-20110213149-A1 | PROCESS FOR PREPARATION OF (2R)-4-OXO-4-[3- (TRIFLUOROMETHYL)-5,6-DIHYDRO [1,2,4]-TRIAZOLO[4,3-A]PYRAZIN- 7(8H)-YL]-L-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE & NEW IMPURITIES IN PREPARATION THEREOF | BPNT1, GART, SLC7A1 | PDPK1 3877/4885PPARG 3145/4885PPARA 2266/4885 |
| US-20080167316-A1 | 6-Heteroaryl-1,2,3,4,4A, 10B-Hexahydrophenanthridines as Pde4-Inhibitors for the Treatment of Inflammatory Disorders | PDE4A, PDE4B, PDE4C | PDPK1 1753/4885PPARG 960/4885PPARA 1867/4885 |
| US-20130165648-A1 | PROCESSES FOR PREPARING 3-BENZAZEPINES | HTR3C, HTR3B, HTR3A | PDPK1 903/4885PPARG 555/4885PPARA 983/4885 |
| US-11168249-B1 | Luminescent polydentate polycyclic compounds for metal ions | PCBP1, CACYBP, CA9 | PDPK1 185/4885PPARG 3850/4885PPARA 2177/4885 |
| US-10125074-B2 | 5-substituted-5-hydroxy-5-aryl-3-oxo-pentanoate derivatives and their enantiopure forms | ADH5, ADH1A, ADH1C | PDPK1 2553/4885PPARG 389/4885PPARA 137/4885 |
| US-20090258904-A1 | Epithiolone Analogues | ESRRB, ESR2, ESRRA | PDPK1 3601/4885PPARG 518/4885PPARA 399/4885 |
| US-20150119389-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE4C | PDPK1 89/4885PPARG 200/4885PPARA 723/4885 |
| US-20080161339-A1 | Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors | PDE4A, PDE4B, PDE4C | PDPK1 326/4885PPARG 686/4885PPARA 1953/4885 |
| US-20160185729-A1 | PROCESSES FOR PREPARING 3-BENZAZEPINES | HTR3C, HTR3B, HTR3A | PDPK1 903/4885PPARG 555/4885PPARA 983/4885 |
| US-20110257169-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | PDE4A, PDE4B, PDE4C | PDPK1 206/4885PPARG 529/4885PPARA 1691/4885 |
| US-20060189645-A1 | Novel 6-phenylphenantridines | PDE4B, PDE4A, PDE4D | PDPK1 426/4885PPARG 2502/4885PPARA 3651/4885 |
| US-20130178620-A1 | PROCESSES FOR PREPARING 3-BENZAZEPINES | HTR3C, HTR3B, HTR3A | PDPK1 903/4885PPARG 555/4885PPARA 983/4885 |
| US-20050239817-A1 | 2-hydroxy-6-phenylphenanthridines as pde-4 inhibitors | PDE4A, PDE4B, PDE3A | PDPK1 215/4885PPARG 1879/4885PPARA 3062/4885 |
| US-20070185149-A1 | Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibtors | PDE4A, PDE4B, PDE4C | PDPK1 573/4885PPARG 607/4885PPARA 1335/4885 |
| US-20160279120-A1 | NOVEL HYDROXY-6-HETEROARYLPHENANTHRIDINES AND THEIR USE AS PDE4 INHIBITORS | PDE4A, PDE12, PDE4B | PDPK1 345/4885PPARG 123/4885PPARA 303/4885 |
| US-20070259909-A1 | Novel Difluoroethoxy-Substituted Hydroxy-6-Phenylphenanthridines and Their Use as Pde4 Inhibitors | PDE4A, PDE4B, PDE4D | PDPK1 207/4885PPARG 496/4885PPARA 1384/4885 |
| US-20070167482-A1 | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiesterase (pde) 4 inhibitors | PDE4A, PDE3A, PDE4B | PDPK1 686/4885PPARG 1638/4885PPARA 3577/4885 |
| US-20180118648-A1 | 5-SUBSTITUTED-5-HYDROXY-5-ARYL-3-OXO-PENTANOATE DERIVATIVES AND THEIR ENANTIOPURE FORMS | ADH5, ADH1A, ADH1C | PDPK1 2553/4885PPARG 389/4885PPARA 137/4885 |
| US-20090233902-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | KIF5A, KIF5C, KIF5B | PDPK1 165/4885PPARG 2548/4885PPARA 4179/4885 |
| US-20040038979-A1 | Treating airway disorders such as asthma. | PTGER4, PDE4B, PDE4A | PDPK1 2593/4885PPARG 1202/4885PPARA 1881/4885 |
| US-20050154051-A1 | Method for the preparation of escitalopram | SLC6A4, TPH2, SLC6A3 | PDPK1 4222/4885PPARG 3882/4885PPARA 4312/4885 |
| US-20080167301-A1 | Respiratory system disorders | PDE4A, PDE4B, PDE12 | PDPK1 735/4885PPARG 427/4885PPARA 1001/4885 |
| US-20080319067-A1 | 2-Hydroxy-6-phenylphenanthridines as PDE-4 inhibitors | PDE4A, PDE4B, PDE3A | PDPK1 215/4885PPARG 1879/4885PPARA 3062/4885 |
| US-20100035913-A1 | Novel guanidinyl-substituted hydroxy-6-phenylphenanthridines as effective phosphodiestrase (PDE) 4 inhibitors | PDE4A, PDE4B, PDE4C | PDPK1 540/4885PPARG 2268/4885PPARA 3715/4885 |
| US-20020183350-A1 | Phenanthridine-n-oxides with pde-iv inhibiting activity | PDE3A, PDE3B, PDE4A | PDPK1 1214/4885PPARG 2466/4885PPARA 3241/4885 |
| US-20050239818-A1 | 3-hydroxy-6-phenylphenanthridines as pde-4 inhibitors | PDE4A, PDE4B, PDE3A | PDPK1 221/4885PPARG 1857/4885PPARA 3036/4885 |
| US-20080214536-A1 | Amido-Substituted 6-Phenylphenanthridines | PDE4A, PDE4B, PDE3A | PDPK1 477/4885PPARG 1617/4885PPARA 2154/4885 |
| US-20090170892-A1 | 3-Hydroxy-6-phenylphenanthridines as pde4 inhibitors | PDE4A, PDE4B, PDE3A | PDPK1 322/4885PPARG 2343/4885PPARA 3500/4885 |
| US-20060116518-A1 | Novel phenanthridines | PDE4A, PDE4B, PDE3A | PDPK1 448/4885PPARG 3183/4885PPARA 3777/4885 |
| US-10633586-B1 | Luminescent polydentate polycyclic compounds for metal ions | PCBP1, CACYBP, CA9 | PDPK1 185/4885PPARG 3850/4885PPARA 2177/4885 |
| US-20070191414-A1 | Novel isoamido-substituted hydroxy-6-phenylphenanthridines | PDE4A, PDE4B, PDE4C | PDPK1 346/4885PPARG 554/4885PPARA 1946/4885 |
| US-20100104659-A1 | BENZOPYRANOPYRAZOLES | BAX, BCL2, BAD | PDPK1 1209/4885PPARG 287/4885PPARA 630/4885 |
| US-20090246169-A1 | INDOLOPYRIDINES AS EG5 KINESIN MODULATORS | KIF5A, KIF5C, KIF5B | PDPK1 165/4885PPARG 2548/4885PPARA 4179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.